US Stock MarketDetailed Quotes
LIPO Lipella Pharmaceuticals
- 2.440
- +0.030+1.25%
Trading Nov 21 14:37 ET
2.95MMarket Cap-568P/E (TTM)
2.750High2.416Low181.10KVolume2.420Open2.410Pre Close465.58KTurnover23.03%Turnover RatioLossP/E (Static)1.21MShares12.00052wk High2.02P/B1.92MFloat Cap2.21052wk Low--Dividend TTM786.30KShs Float61.760Historical High--Div YieldTTM13.88%Amplitude2.210Historical Low2.570Avg Price1Lot Size
About Lipella Pharmaceuticals Company
Lipella Pharmaceuticals, Inc. develops and commercializes lipid-based therapies for common bladder syndromes. It offers LP-08 which consists of Sphingomyelin Phospholipid bilayers separated by aqueous compartments, LP-09, a liposomal formulation of Botulinum toxin, and LP-10, a proprietary liposomal formulation of Tacrolimus, a potent immunosuppressant and anti-inflammatory agent. The company was founded by Jonathan Kaufman and Michael Chancellor on February 15, 2005 and is headquartered in Pittsburgh, PA.
Company Profile
SymbolLIPO
Company NameLipella Pharmaceuticals
Listing DateDec 20, 2022
Founded2005
CEODr. Jonathan Kaufman, M.B.A.,PhD
MarketNASDAQ
Employees7
Fiscal Year Ends12-31
Address7800 Susquehanna Street,Suite 505
CityPittsburgh
ProvincePennsylvania
CountryUnited States of America
Zip Code15208
Phone1-412-901-0315
Websitehttp://www.lipella.com
Company Executives
- Name
- Position
- Salary
- Dr. Jonathan Kaufman, M.B.A.,PhD
- Chairman of the Board, President, Chief Executive Officer, Secretary and Treasurer
- 323.38K
- Dr. Michael Chancellor, M.D.
- Chief Medical Officer and Director
- 315.08K
- Douglas Johnston, C.P.A.
- Chief Financial Officer
- 260.00K
- Dr. Byong Kim, PhD
- Independent Director
- 63.30K
- Ryan Pruchnic, M.B.A.
- Independent Director
- 62.50K
- Dr. Naoki Yoshimura, M.D.,PhD
- Independent Director
- 62.50K
- Dr. Lori Birder, PhD
- Independent Director
- 12.50K
- Daniel R. Cohen, M.B.A.
- Independent Director
- 63.63K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data